USC Norris
>
Clinical Trials
Not logged in...
About USC Norris
Research
Patient Care
Search Trials
FAQ - Trials
Contact Us - Trials
IRB
Membership
Education
Shared Resources
Support USC Norris
Login/Logout
» Contact Us
» Glossary
If you are a patient, please contact
Keck Medical Center of USC
at 800-USC-CARE.
Trial 2N-12-6
A Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-Small Cell Lung Cancer (NSCLC).
Type:
Treatment
Phase:
Phase I/II
Status:
Not Open (Closed)
Treatments:
Chemotherapy: Systemic
Randomized:
Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Barbara Gitlitz, M.D.
Other Trial Staff:
Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Gina Tse, R.N., Eduardo Mejia, D.M., Torsten Fischer, R.N.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.